Health Populi

JULY 26, 2022

For the former, Amazon leadership is talking up the company’s expertise in consumer experience and delight, efficiency and engagement (which I addressed in yesterday’s Day 1 post ). As Mike McSherry from Xealth explained in the GeekWire analysis mentioned earlier, “Would I want Amazon to know that I have a cancer diagnosis?

Primary Care 413

Primary Care BioTech Digital Health Medicare 413

Lloyd Price

FEBRUARY 23, 2025

While giants like UnitedHealth or biotech stars like Vertex Pharmaceuticals often dominate headlines, Doximitys niche focus and execution have propelled it ahead. Healthcare Technology Thought Leadership from Nelson Advisors Market Insights, Analysis & Predictions. Subscribe Today! Subscribe Today!

Telehealth 76

Telehealth Leadership Digital Health BioTech 76

Lloyd Price

MARCH 1, 2025

Big Pharmas looming patent cliffs could drive outlier deals (7-8x or more) for late-stage innovators, especially in biotech-adjacent HealthTech. Healthcare Technology Thought Leadership from Nelson Advisors Market Insights, Analysis & Predictions. This is down from 6.5x Subscribe Today! Subscribe Today!

Telehealth 73

Telehealth Digital Health Leadership Interoperability 73

Lloyd Price

DECEMBER 2, 2024

Healthcare Technology Thought Leadership from Nelson Advisors – Market Insights, Analysis & Predictions. Email lloyd@nelsonadvisors.co.uk HealthTech M&A Newsletter from Nelson Advisors - HealthTech, Health IT, Digital Health Insights and Analysis. Subscribe Today! Subscribe Today!

Digital Health 57

Digital Health healthcare technology Telemedicine Leadership 57

Healthcare IT Today

MARCH 22, 2023

As our ability to utilize data to demonstrate positive clinical outcomes continues to be enhanced through technology, healthcare and biotech companies are under increasing pressure to demonstrate positive clinical outcomes and patient benefits from these investments.

Life Science 114

Life Science BioTech EHR Healthcare IT 114

Digital Health Global

FEBRUARY 5, 2024

Investment Marks a Significant Milestone in Advancing AI-Based Arrhythmia Care SAN DIEGO–(BUSINESS WIRE)– Vektor Medical , a pioneer in non-invasive, AI-based arrhythmia analysis technology, today announced a $16 million Series A investment co-led by Solas BioVentures and TVM Capital Life Science.

Life Science 88

Life Science Pharmaceuticals Medical Technology BioTech 88

Lloyd Price

SEPTEMBER 30, 2024

Medical Imaging: Improving the accuracy and efficiency of diagnostic procedures through AI-powered image analysis. Recursion Pharmaceuticals: A biotech company using AI to discover new drug candidates. Healthcare Technology Thought Leadership from Nelson Advisors – Market Insights, Analysis & Predictions.

BioTech 57

BioTech Pharmaceuticals Leadership healthcare technology 57